Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Collaborative on Healthy Parenting in Primary Care Public Education Campaign CDC, HRSA, SAMHSA NICHD The Collaborative on Healthy Parenting in Primary Care recognizes the accumulated evidence of the effectiveness of family-focused prevention programs that promote the physical and behavioral health and emotional well-being of children from before their birth through adolescence. Members of the Collaborative have united around an initiative to support the integration of effective programs that promote healthy parenting into primary care settings in order to achieve optimal health for children.
Combating Antibiotic Resistant Bacteria (CARB) Resource Development CDC, FDA NLM, NHGRI, NIAID The National Action Plan for Combating Antibiotic-resistant Bacteria is a multi-agency initiative to deal with the threat of increasing antibiotic resistance. NLM's National Center for Biotechnology Information contributes to Sub-Objective 2.1.4: Develop and maintain a national sequence database of resistant bacteria.
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC) Committee, Work group, Advisory group, or Task Force BARDA, CDC NIAID CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. CarbX is led by Boston University with funding from BARDA, NIAID, and other global funding agencies (Wellcome Trust, Germany's BMBF, UK GAMRIF and the Gates Foundation). The Joint Oversight Committee oversees operational, financial and strategic activities. NIAID and BARDA staff also monitor progress for projects in the CarbX portfolio, as well as act as reviewers for new proposals to the program.
Combined Exposures and Mixtures Research Program Research Initiative ATSDR, CDC, FDA, OASH NIEHS Combined Exposures and Mixtures Research Program
Commissioned Corps of the U.S. Public Health Service (USPHS) Oral Health Coordinating Committee (OHCC) Committee, Work group, Advisory group, or Task Force ACF, ACL, AHRQ, CDC, CMS, FDA, OASH, IHS, SAMHSA NIDCR The OHCC includes representatives from HHS and other federal agencies, directs and coordinates a broad range of oral health policy, research, and programs within the USPHS, across federal agencies, and between the public and private sectors. The OHCC contributed to the HHS Oral Health Strategic Framework, 2014-2017 and the update is currently under publication review.
Community Guide Cardiovascular Coordination Team Committee, Work group, Advisory group, or Task Force CDC NHLBI The purpose of the workgroup is to assess the feasibility of and conducting an evidence-based review to assess the effectiveness of interventions using community health workers for cardiovascular disease prevention and other relevant topics. The completed reviews will be included in, “The Community Guide sponsored by the Community Preventive Services Task Force”.
Community Preventive Services Task Force (CPSTF) Committee, Work group, Advisory group, or Task Force CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA OD/DPCPSI/ODP, OD/DPCPSI The Community Preventive Services Task Force (CPSTF) is an independent, non-federal panel of prevention experts that uses information from rigorously conducted systematic evidence reviews to make public health recommendations for preventive services that are delivered in community settings. These recommendations are intended to inform public health decision-making about policy, practice, and research priorities for community preventive services. Recommendations from the CPSTF are published in The Guide to Community Preventive Services. The Office of Disease Prevention (ODP) represents NIH as an official liaison member and works with the CDC and CPSTF members to ensure that recommendations represent the views, concerns, and needs of the NIH and our constituents. ODP staff also serve on, or recommend NIH scientists to serve on systematic evidence review teams, and help translate CPSTF recommendations and insufficient evidence findings into actions.
Computational Toxicology for NIH Medications Discovery Research Initiative FDA NIDA Through an inter-agency agreement, the Food and Drug Administration (FDA) provides structure-activity, relationship-based toxicity predictions for compounds that are under evaluation in the National Institute on Drug Abuse (NIDA) Addiction Treatment Discovery Program. On a limited basis, other National Institutes of Health (NIH) ICs may utilize this resource by working through NIDA.
Computer-aided Diagnosis for Radiology Images Research Initiative FDA CC, OD/OIR This collaboration focuses on the improvement of computer-aided diagnosis for radiology images. Specific applications include computer-aided polyp detection for computed tomography (CT )colonography, improvements in the conduct and analysis of observer performance experiments using radiology images, and the use and development of advanced machine learning and receiver operating characteristics methods with application to computer-aided diagnosis.
Congenital Heart Public Health Consortium Resource Development AHRQ, CDC NHLBI The Congenital Heart Public Health Consortium (CHPHC) is a group of organizations uniting resources and efforts in public health activities. The mission of the CHPHC is to prevent congenital heart defects and improve outcomes for affected children and adults. The consortium achieves its mission by providing leadership and a unified voice for public health priorities, expanding opportunities for surveillance and public health research, and informing public policy priorities that benefit public health and affected persons. The CHPHC represents various federal, state, and community organizations, including those representing patient/family, clinical, and research interests. It is pooling expertise and experience and using a public health model to address Congenital Heart Disease (CHD) issues across the lifespan.